Start Trading Now Get Started
Advertiser Disclosure
Advertiser Disclosure DailyForex.com adheres to strict guidelines to preserve editorial integrity to help you make decisions with confidence. Some of the reviews and content we feature on this site are supported by affiliate partnerships from which this website may receive money. This may impact how, where and which companies / services we review and write about. Our team of experts work to continually re-evaluate the reviews and information we provide on all the top Forex / CFD brokerages featured here. Our research focuses heavily on the broker’s custody of client deposits and the breadth of its client offering. Safety is evaluated by quality and length of the broker's track record, plus the scope of regulatory standing. Major factors in determining the quality of a broker’s offer include the cost of trading, the range of instruments available to trade, and general ease of use regarding execution and market information.

DexCom (DXCM) Stock Signal: Is It Time to Buy at Support?

By Adam Lemon

Adam Lemon began his role at DailyForex in 2013 when he was brought in as an in-house Chief Analyst. Adam trades Forex, stocks and other instruments in his own account. Adam believes that it is very possible for retail traders/investors to secure a positive return over time provided they limit their risks, follow trends, and persevere through short-term losing streaks – provided only reputable brokerages are used. He has previously worked with...

Read more

Long Trade Idea

Enter long short position between 74.21 (the lower band of its horizontal resistance zone) and 75.94 (the upper band of its horizontal resistance zone).

Market Index Analysis

  • DexCom (DXCM) is a member of the NASDAQ 100 and the S&P 500.
  • Both indices trade near records, with mounting concerns about the health of this bull cycle.
  • The Bull Bear Power Indicator of the NASDAQ 100 is bearish with a descending trendline.

Market Sentiment Analysis

Legal drama over President Trump’s tariffs and concerns over the independence of the Federal Reserve will weigh on this week’s sentiment, as investors await Friday’s NFP report. After four months of gains, equity markets enter September, historically the weakest month for bulls. US manufacturing data is due for release today, expected to show contraction and rising prices. Volatility could accelerate amid lower trading volumes as investors rethink portfolios.

DexCom Fundamental Analysis

DexCom is a leader in continuous glucose monitoring (CGM). Its G7 device is the most accurate CGM approved in the US, and DexCom is at the core of the MAHA (Make America Healthy Again) movement.

So, why am I bullish on DXCM after its correction?

The correction eliminated some of the excessive bullishness. It also created a scenario where DXCM has over 30% upside potential. The returns on assets, equity, and invested capital rank among the best in its sector, and DexCom has healthy profit margins. Risks remain to the affordability of G7 to potentially millions of customers amid planned cuts to Medicare, which the sell-off reflected. Finally, the PEG ratio suggests more value ahead.

Dexcom Fundamental

DexCom Fundamental Analysis Snapshot

The price-to-earnings (P/E) ratio of 53.06 makes DXCM an expensive stock. By comparison, the P/E ratio for the NASDAQ 100 is 33.88.

The average analyst price target for DXCM is 102.08. It suggests 30%+ upside potential with manageable downside risks.

DexCom Technical Analysis

Today’s DXCM Signal

DexCom Signal 02/09: Is It Time to Buy at Support? (Chart)

  • The DXCM D1 chart shows a price action inside its horizontal support zone.
  • It also shows price action between its descending 0.0% and 38.2% Fibonacci Retracement Fan levels.
  • The Bull Bear Power Indicator is bearish with an ascending trendline.
  • The average bearish trading volumes show signs of a capitulation sell-off, which often precedes a price action reversal.
  • DXCM corrected as the NASDAQ 100 moved higher, a bearish trading signal, but bullish factors are rising.

Top Forex Brokers

1
Get Started 74% of retail CFD accounts lose money Read Review

My Call on DexCom

I am taking a long position in DXCM between 74.21 and 75.94. The PEG confirms more upside potential, DexCom has a profit potential of over 30% from current levels, and excellent returns on assets, equity, and invested capital. I am buying the support zone.

  • DXCM Entry Level: Between 74.21 and 75.94
  • DXCM Take Profit: Between 87.00 and 89.96
  • DXCM Stop Loss: Between 69.70 and 71.71
  • Risk/Reward Ratio: 2.84

Ready to trade our free daily signals? Here is our list of the best brokers for trading worth checking out.

Adam Lemon began his role at DailyForex in 2013 when he was brought in as an in-house Chief Analyst. Adam trades Forex, stocks and other instruments in his own account. Adam believes that it is very possible for retail traders/investors to secure a positive return over time provided they limit their risks, follow trends, and persevere through short-term losing streaks – provided only reputable brokerages are used. He has previously worked within financial markets over a 12-year period, including 6 years with Merrill Lynch.

Most Visited Forex Broker Reviews